These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34679256)

  • 101. Tissue Expression of Programmed Cell Death 1 Ligand1 (PD-L1) in Biopsies of Transplant Livers of Pediatric Patients as a Possible Marker of Acute Cellular Rejection.
    Szymanska S; Markiewicz-Kijewska M; Pyzlak M; Karkucinska-Wienckowska A; Ciopinski M; Czubkowski P; Kaliciński P
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445304
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts.
    Dieudé M; Turgeon J; Karakeussian Rimbaud A; Beillevaire D; Qi S; Patey N; Gaboury LA; Boilard É; Hébert MJ
    Am J Transplant; 2020 Mar; 20(3):726-738. PubMed ID: 31729155
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Fate of transplanted lungs is controlled by immune cells encounter within pulmonary allografts.
    Degauque N
    Am J Transplant; 2018 Jan; 18(1):9-10. PubMed ID: 28887863
    [No Abstract]   [Full Text] [Related]  

  • 104. Corrigendum to "Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression" [American Journal of Transplantation (2022) 2571-2585].
    Paul PK; Das R; Drow T; Nylen EA; Henrique de Souza A; Wang Z; Wood MW; Davis DB; Bjorling DE; Galipeau J
    Am J Transplant; 2023 May; 23(5):693. PubMed ID: 36907701
    [No Abstract]   [Full Text] [Related]  

  • 105. Neutrophils cause a "NET" increase in skin allograft allogenicity.
    Brouard S; Mooney N
    Am J Transplant; 2020 Apr; 20(4):922-923. PubMed ID: 31846552
    [No Abstract]   [Full Text] [Related]  

  • 106. Prolongated and large dose of r-ATG relieves PD-L1 inhibitor-induced allograft rejection in liver transplant recipient.
    Zhang YJ; Zhou DJ; Li H; Pan Q; Cheng Y
    Hepatobiliary Pancreat Dis Int; 2024 May; ():. PubMed ID: 38845248
    [No Abstract]   [Full Text] [Related]  

  • 107. National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan.
    Yoshimoto-Haramura T; Hidaka M; Hasegawa K; Suzumura K; Takemura N; Hama N; Mizuno T; Nomi T; Kobayashi T; Sano K; Yokomizo H; Nitta H; Kurata M; Hasegawa Y; Nagayama M; Tani M; Fukumoto T; Ohta M; Hayashi H; Taniguchi H; Ishino S; Aihara T; Murase T; Tsuchida A; Shimamura T; Marubashi S; Kaneko J; Hara T; Matsushima H; Soyama A; Endo T; Eguchi S
    J Hepatobiliary Pancreat Sci; 2022 Mar; 29(3):385-393. PubMed ID: 34726831
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
    Jiang J; Huang H; Chen R; Lin Y; Ling Q
    Front Immunol; 2023; 14():1092401. PubMed ID: 36875077
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Blockade or deficiency of PD-L1 expression in intestinal allograft accelerates graft tissue injury in mice.
    Matsushima H; Morita-Nakagawa M; Datta S; Pavicic PG; Hamilton TA; Abu-Elmagd K; Fujiki M; Osman M; D'Amico G; Eguchi S; Hashimoto K
    Am J Transplant; 2022 Mar; 22(3):955-965. PubMed ID: 34679256
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
    Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
    J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
    Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
    J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
    [TBL] [Abstract][Full Text] [Related]  

  • 113. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
    Front Immunol; 2019; 10():306. PubMed ID: 30863408
    [TBL] [Abstract][Full Text] [Related]  

  • 114. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.